In this #3 Open Webinar | Making ePI a Reality presentation, you will find:
The final presentation was done by PharmaLedger’s ePI Use Case Co-Lead Patrick Maher (Novartis), who highlighted the next development steps, aims and milestones of the use case.
This presentation includes:
- ePI product pipeline, 2022 and beyond
- PharmaLedger Next Generation
- Necessary steps to have the ePI solution adopted
- Closing remarks
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 853992. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.
Disclaimer: Any information on this presentation solely reflects the author’s view and neither IMI nor the European Union or EFPIA are responsible for any use that may be made of the information contained herein.